Metabolic and Molecular Mechanisms of NAFLD/NASH
Metabolic and Molecular Mechanisms of NAFLD/NASH
批准号:
10682156
负责人:
TERRY L. SHEPPARD
金额:
$1.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
已结题
起止时间:
2023-02-15 至 2024-01-31
关键词:
Alberta provinceAntidiabetic DrugsAreaBiological ProcessBiologyBiotechnologyCanadaCareer MobilityClinicalCollaborationsCommunitiesDataDedicationsDevelopmentDiabetes MellitusDiagnosticDiseaseEducationEducational workshopEventFibrosisFosteringGeneticGoalsGrowthHepaticHepatocyteHistologicIndustryInflammationInflammatoryInsulin ResistanceJointsKnowledgeLearningLife Style ModificationLipidsLiverLiver FibrosisLiver diseasesLobularMediatorMedicalMetabolicMetabolic DiseasesMetabolic syndromeMethodologyMolecularMorbidity - disease rateObesityOrganOutcomeParticipantPathogenesisPathogenicityPathway interactionsPharmacologic SubstanceProgressive DiseaseRegulationResearchResearch PersonnelResolutionRoleScientistSteatohepatitisTestingTherapeutic AgentsTherapeutic InterventionThinkingUpdateWeight-Loss DrugsWorkcareerclinical practicedesignimprovedliver inflammationliver transplantationmortalitymultidisciplinarynext generationnon-alcoholic fatty liver diseasenonalcoholic steatohepatitispostersprogramssymposium
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
Support is requested for a Keystone Symposia conference entitled Metabolic and Molecular Mechanisms of
NAFLD/NASH, organized by Drs. James Trevaskis, Jacquelyn Maher and Quentin Anstee. The conference
will be held in Banff, Alberta, Canada from March 19 - 23, 2023.
Non-alcoholic fatty liver disease (NAFLD) and steatohepatitis (NASH) represents the hepatic manifestation of
the metabolic syndrome and is emerging as a key driver of morbidity and mortality, particularly when present in
the context of severe liver fibrosis. The histological hallmarks of NASH including steatosis, lobular
inflammation and hepatocyte ballooning are well-characterized; however, while it is widely recognized that
NASH is a progressive disease, the pathogenic and molecular mechanisms that initiate and drive NASH
remain largely unknown. Therefore, this conference was designed to bring together a broad group of scientific
and clinical researchers to highlight and discuss the current evidence exploring the key biological processes
involved in NASH and liver fibrosis. This conference program will cover topics such as insulin resistance,
hepatocyte lipid management/lipotoxicity and inflammation in the context of steatosis and NASH. Furthermore,
advances in our understanding of the molecular and genetic regulation of NAFLD/NASH and the progression
to liver fibrosis will also be highlighted. Finally, as NASH is an unmet medical need, this program will integrate
the earlier fundamental biology discussion with updates on clinical progress of therapeutic agents, and
combinations of agents, for the treatment of NASH and liver fibrosis. Finally, this conference will be held jointly
with Fibrosis Pathogenesis and Resolution: From Mechanisms to Therapies. The joint conference will focus on
the key cellular drivers and mediators of fibrosis in organs beyond the liver and allows for cross-functional
discussion and deeper understanding of pathobiology of fibrotic disease. Participants from both conferences
will have the opportunity to network through shared sessions, mealtimes, and evening poster sessions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Pulmonary Hypertension: State of the Art and Therapeutic Opportunities
-
批准号:10682118
-
项目类别:
-
资助金额:$1.53万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Infections in Pregnancy: PathogenicMechanisms, Experimental Advances and Clinical Strategies
-
批准号:10540260
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Mechanisms of Microbiota-Immune Interactions-Towards the Next Decade
-
批准号:10753451
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Vaccinology During and After COVID-19
-
批准号:10753782
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Transposable Elements at the Crossroads of Evolution, Health and Disease
-
批准号:10750852
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment
-
批准号:10749522
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
B Cell Biology in the Context of Infectious Diseases, Autoimmunity and B Cell Cancers
-
批准号:10683443
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Metastasis
-
批准号:10681132
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Inflammation in the Lung: Friend or Foe in Viral Infections?
-
批准号:10681956
-
项目类别:
-
资助金额:$1.5万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
HIV Vaccines, Immunoprophylaxis and Drugs
-
批准号:10699245
-
项目类别:
-
资助金额:$2.13万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
B Cells and Tertiary Lymphoid Structures: Emerging Targets in Cancer Therapeutics
-
批准号:10754008
-
项目类别:
-
资助金额:$0.6万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Myeloid Cell Diversity: From Fundamental Biology to Disease States
-
批准号:10753412
-
项目类别:
-
资助金额:$1.25万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
RNA Modifications in Health and Disease
-
批准号:10754076
-
项目类别:
-
资助金额:$0.75万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Emerging Cellular Therapies at the Forefront of Cancer Immunotherapy
-
批准号:10540496
-
项目类别:
-
资助金额:$1.1万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
From First Breath: Lung Development, Infection, Repair and Aging
-
批准号:10678811
-
项目类别:
-
资助金额:$1.65万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Precision Genome Engineering
-
批准号:10608865
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
T and B Cell Collaboration in Germinal Centers and Beyond
-
批准号:10753621
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Type 2 Diabetes: Understanding its Early Drivers and the Road to Therapeutics
-
批准号:10682747
-
项目类别:
-
资助金额:$1.32万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Heart Development and Disease: From Genes to Cures
-
批准号:10608624
-
项目类别:
-
资助金额:$1.62万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
Signals and Mechanisms Underlying the Benefits of Exercise
-
批准号:10750822
-
项目类别:
-
资助金额:$1.89万
-
财政年份:2023
-
负责人:TERRY L. SHEPPARD
-
依托单位:
海外基金